Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
CAS No. : | 1021-25-6 | MDL No. : | MFCD00005977 |
Formula : | C13H17N3O | Boiling Point : | No data available |
Linear Structure Formula : | - | InChI Key : | HTQWGIHCFPWKAS-UHFFFAOYSA-N |
M.W : | 231.29 | Pubchem ID : | 70556 |
Synonyms : |
|
Signal Word: | Warning | Class: | |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | |
Hazard Statements: | H315-H319-H335 | Packing Group: | |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride; sodium tris(acetoxy)borohydride; In CHCl3:CH3OH; diethyl ether; 1,2-dichloro-ethane; | Step B To a mixture of <strong>[223575-69-7]2-(2-thiazolyl)benzaldehyde</strong> (200 mg, 1.06 mmol) and 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (0.232 mg, 1.00 mmol) in 1,2-dichloroethane (20 mL) was added sodium triacetoxyborohydride (376 mg, 1.79 mmol). The resultant mixture was stirred at room temperature for 18 h, quenched with aqueous NaHCO3 (50 mL) and extracted with CHCl3 (2*50 mL). The organic solution was dried over Na2SO4, filtered and concentrated. The crude product was dissolved in 1:1 CHCl3:CH3OH (30 mL) and treated with 2 mL of 1 N HCl in Et2O. The HCl salt was precipitated by addition of Et2O, collected by filtration and dried in the vacuum oven at 60 C. for 18 h to yield the product as an amorphous solid. MS (loop pos): MH+=405.1 (100%) 1H NMR (300 MHz, DMSO d6) 61.50-1.60 (m, 2H), 2.75-2.90 (m, 2H), 3.45-3.55 (m, 2H), 3.75-3.90 (m, 2H), 4.65 (s, 2H), 4.70 (s, 2H), 6.76-6.81 (m, 1H), 6.95-6.98 (m, 2H), 7.18-7.24 (m, 2H), 7.60-7.70 (m, 2H), 7.90-7.99 (m, 3H), 8.14-8.15 (m, 1H), 9.00 (s, 1H), 9.80 (br s, 1H exchangeable). | |
With sodium tris(acetoxy)borohydride; In 1,2-dichloro-ethane; at 20℃; for 18h; | Step B: To a mixture of <strong>[223575-69-7]2-(2-thiazolyl)benzaldehyde</strong> (200 mg, 1.06 mmol) and 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (.232 mg, 1.00 mmol) in 1,2-dichloroethane (20 mL) was added sodium triacetoxyborohydride (376 mg, 1.79 mmol). The resultant mixture was stirred at room temperature for 18h, quenched with aqueous NaHCO3 (50 mL) and extracted with CHCl3 (2 x 50 mL). The organic solution was dried over Na2SO4, filtered and concentrated. The crude product was dissolved in 1:1 CHCl3: CH3OH (30 mL) and treated with 2 mL of 1 N HCl in Et2O. The HCl salt was precipitated by addition of Et2O, collected by filtration and dried in the vacuum oven at 60C for 18h to yield the product as an amorphous solid. MS (loop pos): MH+ = 405.1 (100%) 1H NMR (300 MHz, DMSO d6) delta 1.50-1.60 (m, 2H), 2.75-2.90 (m, 2H), 3.45-3.55 (m, 2H), 3.75-3.90 (m, 2H), 4.65 (s, 2H), 4.70 (s, 2H), 6.76-6.81 (m, 1 H), 6.95-6.98 (m, 2H), 7.18-7.24 (m, 2H), 7.60-7.70 (m, 2H), 7.90-7.99 (m, 3H), 8.14-8.15 (m, 1H), 9.00 (s, 1H), 9.80 (br s, 1 H exchangeable). |
[ 1272758-31-2 ]
3-Phenyl-1,3,8-triazaspiro[4.5]decan-4-one
Similarity: 0.99
[ 170921-48-9 ]
8-Benzyl-1,3,8-triazaspiro[4.5]decan-4-one
Similarity: 0.75
[ 96-88-8 ]
N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide
Similarity: 0.69
[ 38396-39-3 ]
1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
Similarity: 0.69
[ 1272758-31-2 ]
3-Phenyl-1,3,8-triazaspiro[4.5]decan-4-one
Similarity: 0.99
[ 170921-48-9 ]
8-Benzyl-1,3,8-triazaspiro[4.5]decan-4-one
Similarity: 0.75
[ 80636-30-2 ]
3,3-Dimethyl-3,4-dihydroquinoxalin-2(1H)-one
Similarity: 0.70
[ 96-88-8 ]
N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide
Similarity: 0.69
[ 86499-35-6 ]
3-Amino-2,3,4,5-tetrahydro-1H-benzazepin-2-one
Similarity: 0.63
[ 1243415-14-6 ]
4-Methyl-3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one
Similarity: 0.62
[ 5755-07-7 ]
1,3,4,5-Tetrahydro-2H-1,5-benzodiazepin-2-one
Similarity: 0.60
[ 46155-89-9 ]
1,3-Dimethyl-1H-pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione
Similarity: 0.58
[ 1000981-77-0 ]
2,3-Dihydroimidazo[1,2-a]pyridin-5(1H)-one
Similarity: 0.56
[ 1272758-31-2 ]
3-Phenyl-1,3,8-triazaspiro[4.5]decan-4-one
Similarity: 0.99
[ 170921-48-9 ]
8-Benzyl-1,3,8-triazaspiro[4.5]decan-4-one
Similarity: 0.75
[ 2221-13-8 ]
3-Phenylimidazolidine-2,4-dione
Similarity: 0.69
[ 13625-39-3 ]
1,3,8-Triazaspiro[4.5]decane-2,4-dione
Similarity: 0.68
[ 78222-09-0 ]
1,3,7-Triazaspiro[4.5]decane-2,4-dione
Similarity: 0.67
[ 1272758-31-2 ]
3-Phenyl-1,3,8-triazaspiro[4.5]decan-4-one
Similarity: 0.99
[ 170921-48-9 ]
8-Benzyl-1,3,8-triazaspiro[4.5]decan-4-one
Similarity: 0.75
[ 13625-39-3 ]
1,3,8-Triazaspiro[4.5]decane-2,4-dione
Similarity: 0.68
[ 78222-09-0 ]
1,3,7-Triazaspiro[4.5]decane-2,4-dione
Similarity: 0.67
[ 699-51-4 ]
1,3-Diazaspiro[4.4]nonane-2,4-dione
Similarity: 0.63